Clinical Trial Update: Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial evaluating the topical DA-4001 for androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• DA-4001

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Androgenetic Alopecia | Phase 1, Phase 2 | Status: COMPLETED